KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terawulf (WULF) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Terawulf (WULF) over the last 17 years, with Q3 2025 value amounting to $711.3 million.

  • Terawulf's Cash & Equivalents rose 287148.88% to $711.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $711.3 million, marking a year-over-year increase of 287148.88%. This contributed to the annual value of $274.1 million for FY2024, which is 40349.93% up from last year.
  • Per Terawulf's latest filing, its Cash & Equivalents stood at $711.3 million for Q3 2025, which was up 287148.88% from $90.0 million recorded in Q2 2025.
  • In the past 5 years, Terawulf's Cash & Equivalents ranged from a high of $711.3 million in Q3 2025 and a low of $1.5 million during Q3 2021
  • Its 5-year average for Cash & Equivalents is $86.8 million, with a median of $17.0 million in 2023.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 8378.75% in 2022, then skyrocketed by 287148.88% in 2025.
  • Quarter analysis of 5 years shows Terawulf's Cash & Equivalents stood at $43.4 million in 2021, then plummeted by 83.79% to $7.0 million in 2022, then surged by 672.84% to $54.4 million in 2023, then skyrocketed by 403.5% to $274.1 million in 2024, then skyrocketed by 159.51% to $711.3 million in 2025.
  • Its Cash & Equivalents was $711.3 million in Q3 2025, compared to $90.0 million in Q2 2025 and $218.2 million in Q1 2025.